官方服务：
资源简介：
Antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells
应用场景：
创建时间：
2025-01-24
相关数据集
Gene expression profile of H187-63AR, an ABT-737 resistant derivative of H187. Homo sapiens
ABT-737 is a highly potent small molecule inhibitor of Bcl-2 which has demonstrated efficacy in preclinical studies. To identify factors which mediate ABT-737 sensitivity we created an ABT-737-resista
NIAID Data Ecosystem80
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence. Homo sapiens
Diverse pathways can drive resistance to BRAF and MEK inhibitors in BRAF mutant melanoma, suggesting that durable control of resistance will be a major challenge. By combining statistical modeling of
NIAID Data Ecosystem70
Additional file 3 of Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer
Additional file 3.
NIAID Data Ecosystem30
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies. Targeting WNT pathway in MAPK resistant CRC
Attempts at eradicating metastatic cancers with targeted therapies are limited by the emergence of resistant sub-clones bearing heterogeneous (epi)genetic changes. Here we use colorectal cancer to tes
NIAID Data Ecosystem70
KDM5B links cellular transcriptome heterogeneity to therapy resistance (RRBS)
The KDM5B histone H3 lysine 4 (H3K4) demethylase has been implicated in therapy resistance in multiple cancer types including breast cancer, but the underlying mechanism is poorly defined. Here we sho
NIAID Data Ecosystem30
